• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续的患者来源的腺样囊性癌原位异种移植重现了表型改变和神经支配的稳定表达。

Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation.

机构信息

University of Michigan, Biointerfaces Institute, Ann Arbor, MI, United States; University of Michigan, School of Dentistry, Department of Biologic and Materials Sciences, Ann Arbor, MI, United States.

University of Virginia, School of Medicine, Department of Pathology, Charlottesville, VA, United States.

出版信息

EBioMedicine. 2019 Mar;41:175-184. doi: 10.1016/j.ebiom.2019.02.011. Epub 2019 Feb 11.

DOI:10.1016/j.ebiom.2019.02.011
PMID:30765319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6442226/
Abstract

BACKGROUND

Patient-derived xenograft (PDX) models have significantly enhanced cancer research, and often serve as a robust model. However, enhanced growth rate and altered pathological phenotype with serial passages have repeatedly been shown in adenoid cystic carcinoma (ACC) PDX tumors, which is a major concern.

METHODS

We evaluated the fidelity of ACCs in their natural habitat by performing ACC orthotopic xenotransplantation (PDOX) in salivary glands.

FINDINGS

Our PDOX model enabled solid tumors to integrate within the local epithelial, stromal and neuronal environment. Over serial passages, PDOX tumors maintained their stereotypic MYB-NFIB translocation, and FGFR2 and ATM point mutations. Tumor growth rate and histopathology were retained, including ACCs hallmark presentations of cribriform, tubular, solid areas and innervation. We also demonstrate that the PDOX model retains its capacity as a tool for drug testing.

INTERPRETATION

Unlike the precedent PDX model, our data shows that the PDOX is a superior model for future cancer biology and therapy research. FUND: This work was supported by the National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) grants DE022557, DE027034, and DE027551.

摘要

背景

患者来源的异种移植(PDX)模型显著促进了癌症研究,并且通常作为一种强大的模型。然而,在腺样囊性癌(ACC)PDX 肿瘤中,连续传代后肿瘤的生长速度加快和病理表型改变的情况屡有报道,这是一个主要关注点。

方法

我们通过在唾液腺中进行腺样囊性癌的原位异种移植(PDOX)来评估 ACC 在其自然栖息地中的保真度。

发现

我们的 PDOX 模型使实体瘤能够整合到局部上皮、基质和神经元环境中。在连续传代过程中,PDOX 肿瘤保持其典型的 MYB-NFIB 易位以及 FGFR2 和 ATM 点突变。肿瘤的生长速度和组织病理学特征得以保留,包括 ACC 的筛状、管状、实体区域和神经支配等特征。我们还证明了 PDOX 模型保留了作为药物测试工具的能力。

解释

与先前的 PDX 模型不同,我们的数据表明 PDOX 是未来癌症生物学和治疗研究的更优模型。

资金

这项工作得到了美国国立卫生研究院(NIH)/国家牙科和颅面研究所(NIDCR)授予的 DE022557、DE027034 和 DE027551 资助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/1fb329d24b34/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/204057b48f47/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/90f3cd86307d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/6c71de9facbe/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/1fb329d24b34/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/204057b48f47/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/90f3cd86307d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/6c71de9facbe/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb4/6442226/1fb329d24b34/gr4.jpg

相似文献

1
Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation.连续的患者来源的腺样囊性癌原位异种移植重现了表型改变和神经支配的稳定表达。
EBioMedicine. 2019 Mar;41:175-184. doi: 10.1016/j.ebiom.2019.02.011. Epub 2019 Feb 11.
2
Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.采用类器官培养法建立 PDX 来源的唾液腺腺样囊性癌细胞系。
Int J Cancer. 2021 Jan 1;148(1):193-202. doi: 10.1002/ijc.33315. Epub 2020 Oct 7.
3
UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.UM-HACC-2A:MYB-NFIB 融合阳性的人腺样囊性癌细胞系。
Oral Oncol. 2018 Dec;87:21-28. doi: 10.1016/j.oraloncology.2018.10.012. Epub 2018 Oct 18.
4
MYB-NFIB Translocation by FISH in Adenoid Cystic Carcinoma of the Head and Neck in Nigerian Patients: A Preliminary Report.MYB-NFIB 易位的头颈部腺样囊性癌患者在尼日利亚的 FISH 分析:初步报告。
Head Neck Pathol. 2021 Jun;15(2):433-437. doi: 10.1007/s12105-020-01214-3. Epub 2020 Aug 28.
5
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.头颈部腺样囊性癌中的MYB重排及临床病理特征
Laryngoscope. 2015 Sep;125(9):E292-9. doi: 10.1002/lary.25356. Epub 2015 May 11.
6
Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.通过抑制 IGF1R/AKT 信号通路靶向腺样囊性癌的致癌转录调节因子 MYB。
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx017.
7
A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.一部分前列腺基底细胞癌存在腺样囊性癌的MYB重排。
Hum Pathol. 2015 Aug;46(8):1204-8. doi: 10.1016/j.humpath.2015.05.002. Epub 2015 May 22.
8
Patient-derived xenograft (PDX) tumors increase growth rate with time.患者来源的异种移植(PDX)肿瘤的生长速率会随时间增加。
Oncotarget. 2016 Feb 16;7(7):7993-8005. doi: 10.18632/oncotarget.6919.
9
Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.在缺乏t(6;9)易位的涎腺腺样囊性癌中具有复发性MYBL1-NFIB融合的新型MYBL1基因重排
Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.
10
Adenoid cystic carcinoma: clinical and molecular features.腺样囊性癌:临床与分子特征
Head Neck Pathol. 2013 Mar;7(1):17-22. doi: 10.1007/s12105-013-0426-3. Epub 2013 Mar 5.

引用本文的文献

1
Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances.腺样囊性癌:分子特征与治疗进展的见解
MedComm (2020). 2024 Sep 11;5(9):e734. doi: 10.1002/mco2.734. eCollection 2024 Sep.
2
Molecular characterization of the salivary adenoid cystic carcinoma immune landscape by anatomic subsites.基于解剖部位对唾液腺腺样囊性癌免疫图谱的分子特征分析。
Sci Rep. 2024 Jul 9;14(1):15821. doi: 10.1038/s41598-024-66709-3.
3
Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models.

本文引用的文献

1
Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.唾液腺癌患者来源异种移植物可用于鉴定癌症干细胞和与肿瘤进展相关的新基因事件。
Clin Cancer Res. 2018 Jun 15;24(12):2935-2943. doi: 10.1158/1078-0432.CCR-17-3871. Epub 2018 Mar 19.
2
Genetic and metabolic comparison of orthotopic and heterotopic patient-derived pancreatic-cancer xenografts to the original patient tumors.原位和异位患者来源的胰腺癌异种移植瘤与原始患者肿瘤的基因和代谢比较。
Oncotarget. 2017 Dec 21;9(8):7867-7881. doi: 10.18632/oncotarget.23567. eCollection 2018 Jan 30.
3
非小细胞肺癌小鼠模型的研究现状及中药在小鼠模型中的抗肿瘤治疗
Evid Based Complement Alternat Med. 2022 Sep 21;2022:6404853. doi: 10.1155/2022/6404853. eCollection 2022.
4
Patient-derived intrafemoral orthotopic xenografts of peripheral blood or bone marrow from acute myeloid and acute lymphoblastic leukemia patients: clinical characterization, methodology, and validation.患者来源的外周血或骨髓的股骨内原位异种移植在急性髓系和急性淋巴细胞白血病患者中的临床特征、方法学和验证。
Clin Exp Med. 2023 Aug;23(4):1293-1306. doi: 10.1007/s10238-022-00884-3. Epub 2022 Sep 19.
5
Establishment of patient-derived xenograft models of adenoid cystic carcinoma to assess pre-clinical efficacy of combination therapy of a PI3K inhibitor and retinoic acid.建立腺样囊性癌患者来源的异种移植模型以评估PI3K抑制剂与视黄酸联合治疗的临床前疗效。
Am J Cancer Res. 2021 Mar 1;11(3):773-792. eCollection 2021.
6
Impact of Tumor Site and Adjuvant Radiotherapy on Survival of Patients with Adenoid Cystic Carcinoma: A SEER Database Analysis.肿瘤部位及辅助放疗对腺样囊性癌患者生存的影响:一项监测、流行病学和最终结果(SEER)数据库分析
Cancers (Basel). 2021 Feb 3;13(4):589. doi: 10.3390/cancers13040589.
7
Ultrasound guided generation of PDOX models of adenoid cystic carcinoma.超声引导下腺样囊性癌PDOX模型的建立
EBioMedicine. 2019 Apr;42:38. doi: 10.1016/j.ebiom.2019.03.084. Epub 2019 Apr 4.
8
Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.腺样囊性癌的临床整合分子诊断。
Oncologist. 2019 Oct;24(10):1356-1367. doi: 10.1634/theoncologist.2018-0515. Epub 2019 Mar 29.
9
Orthotopic tumours, a hot topic for xenograft models?原位肿瘤,异种移植模型的热门话题?
EBioMedicine. 2019 Mar;41:11-12. doi: 10.1016/j.ebiom.2019.02.052. Epub 2019 Mar 1.
Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
在结直肠癌和肝转移的 PDX 模型中,鼠类基质细胞呈现出类似人类的代谢表型。
Oncogene. 2018 Mar;37(9):1237-1250. doi: 10.1038/s41388-017-0018-x. Epub 2017 Dec 15.
4
Patient-derived xenografts undergo mouse-specific tumor evolution.患者来源的异种移植瘤经历小鼠特异性肿瘤进化。
Nat Genet. 2017 Nov;49(11):1567-1575. doi: 10.1038/ng.3967. Epub 2017 Oct 9.
5
A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug.一种用于唾液腺癌腺样囊性癌的多重临床前模型鉴定regorafenib 为一种潜在的治疗药物。
Sci Rep. 2017 Sep 12;7(1):11410. doi: 10.1038/s41598-017-11764-2.
6
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation.建立并鉴定用于临床前药物评估的原位人源第 3 组髓母细胞瘤模型。
Sci Rep. 2017 Apr 18;7:46366. doi: 10.1038/srep46366.
7
Interrogating open issues in cancer precision medicine with patient-derived xenografts.用患者来源异种移植技术探究癌症精准医学中的未决问题。
Nat Rev Cancer. 2017 Apr;17(4):254-268. doi: 10.1038/nrc.2016.140. Epub 2017 Jan 20.
8
Patient-derived xenograft (PDX) models in basic and translational breast cancer research.基础及转化性乳腺癌研究中的患者来源异种移植(PDX)模型
Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x.
9
Patient-derived xenografts: a relevant preclinical model for drug development.患者来源的异种移植:药物开发相关的临床前模型。
J Exp Clin Cancer Res. 2016 Dec 5;35(1):189. doi: 10.1186/s13046-016-0462-4.
10
Patient-derived mouse models of cancer need to be orthotopic in order to evaluate targeted anti-metastatic therapy.为了评估靶向抗转移治疗,源自患者的癌症小鼠模型需要是原位的。
Oncotarget. 2016 Nov 1;7(44):71696-71702. doi: 10.18632/oncotarget.12322.